MedPath

Tandospirone

Generic Name
Tandospirone
Drug Type
Small Molecule
Chemical Formula
C21H29N5O2
CAS Number
87760-53-0
Unique Ingredient Identifier
190230I669
Background

Tandospirone has been used in trials studying the treatment of Schizophrenia.

Indication

1.各种神经症所致的焦虑状态，如广泛性焦虑障碍；

2.原发性高血压、消化性溃疡等躯体病伴发的焦虑症状。

Clinical Trials
Related News

Comparison of Tandospirone, Amlodipine and Their Combination in Adults With Hypertension and Anxiety

First Posted Date
2018-09-12
Last Posted Date
2018-12-04
Lead Sponsor
Chongqing Medical University
Target Recruit Count
256
Registration Number
NCT03667677
Locations
🇨🇳

Beijing Friendship Hospital of Capital Medical University, Beijing, Beijing, China

🇨🇳

Yongchuan Hospital of Chongqing Medical University, Chongqing, Chongqing, China

🇨🇳

Beijing Haidian Section of Peking University Third Hospital, Beijing, Beijing, China

and more 4 locations

A Based on PEEG and PET Study of Anxiolytic Treatment to Improve Cognitive Function in Patients With Alzheimer Disease

Phase 4
Conditions
Cognitive Function
Alzheimer Disease
Interventions
First Posted Date
2017-05-12
Last Posted Date
2017-05-12
Lead Sponsor
Zhejiang Provincial People's Hospital
Target Recruit Count
30
Registration Number
NCT03151382

Tandospirone Combined With Atypical Antipsychotic Drugs in Schizophrenia

Phase 4
Conditions
Schizophrenia
Interventions
Drug: Risperidone/Olanzapine/Quetiapine/Ziprasidone/Aripiprazole
First Posted Date
2014-01-20
Last Posted Date
2014-01-20
Lead Sponsor
Qingyun Yin
Target Recruit Count
100
Registration Number
NCT02040883
Locations
🇨🇳

Guangzhou Psychiatric Hospital, Guangzhou, Guangdong, China

Geographic Atrophy Treatment Evaluation

Phase 3
Terminated
Conditions
Age-Related Macular Degeneration
Geographic Atrophy
Interventions
Drug: AL-8309B Vehicle
First Posted Date
2009-04-29
Last Posted Date
2014-07-03
Lead Sponsor
Alcon Research
Target Recruit Count
772
Registration Number
NCT00890097
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy